Literature DB >> 2912045

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination.

S L Cochi1, L E Edmonds, K Dyer, W L Greaves, J S Marks, E Z Rovira, S R Preblud, W A Orenstein.   

Abstract

The National Congenital Rubella Syndrome Registry, a passive surveillance system, and the Birth Defects Monitoring Program, a newborn hospital discharge data set, are used to monitor the incidence of congenital rubella syndrome in the United States. Reports to the registry contain clinical and laboratory data which allow cases to be classified into six categories according to the likelihood of having congenital rubella syndrome. The monitoring program records newborn discharge diagnoses, without detailed information, of a nonrandom sample of about one fourth of the births in the United States annually. To evaluate the two systems and to estimate the actual incidence of congenital rubella syndrome, the authors collected hospital discharge summaries on all cases as reported by the monitoring program from 1970-1985 and classified them by the registry criteria. Of the 392 cases reported to the monitoring program during 1970-1985, 24% (n = 93) could be classified as confirmed or compatible compared with 79% (n = 415) of the 526 cases reported to the registry (rate ratio = 3.3; 95% confidence interval (CI) 2.9-3.8). Diagnosis of congenital rubella syndrome was made during the neonatal period for 68% (263 of 389) registry cases for whom such data were available. When the Lincoln-Peterson capture-recapture method of estimating population size for independent surveillance systems was used, an estimated 1,064 confirmed and compatible cases (95% CI 668-1,460) diagnosed during the neonatal period occurred during 1970-1979, for an average of 106 cases per year. During 1980-1985, an estimate of 122 neonatal confirmed and compatible cases (95% CI 8-236) occurred, for an average of 20 cases per year. A downward secular trend in the incidence of congenital rubella syndrome beginning in 1980 was observed. The registry detected 22% of all neonatal confirmed and compatible cases, the monitoring program detected 8%, and the two systems combined detected a total of 28%. The results indicate that congenital rubella syndrome may be on the verge of elimination in the United States.

Entities:  

Mesh:

Year:  1989        PMID: 2912045     DOI: 10.1093/oxfordjournals.aje.a115138

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  30 in total

1.  Evaluation of the completeness of reporting of invasive meningococcal disease.

Authors:  P Rivest; B Sagot; L Bédard
Journal:  Can J Public Health       Date:  1999 Jul-Aug

2.  Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana.

Authors:  J E Lawn; S Reef; B Baffoe-Bonnie; S Adadevoh; E O Caul; G E Griffin
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 3.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Estimating the incidence of coeliac disease with capture-recapture methods within four geographic areas in Italy.

Authors:  G Corrao; P Usai; G Galatola; N Ansaldi; A Meini; M A Pelli; G Castellucci; G R Corazza
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

5.  The reporting sensitivities of two passive surveillance systems for vaccine adverse events.

Authors:  S Rosenthal; R Chen
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

6.  Using the two-source capture-recapture method to estimate the incidence and case ascertainment of congenital rubella syndrome in Australia, 1993-2013.

Authors:  Nicolee Martin; David Durrheim; Gulam Khandaker; Michelle Butler; Cheryl Jones
Journal:  Western Pac Surveill Response J       Date:  2016-03-29

7.  Incidence of type 1 (insulin-dependent) diabetes mellitus in subjects 0-14 years of age in the Comunidad of Madrid, Spain.

Authors:  M Serrano Ríos; C S Moy; R Martín Serrano; A Minuesa Asensio; M E de Tomás Labat; G Zarandieta Romero; J Herrera
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

8.  Reporting efficiency during a measles outbreak in New York City, 1991.

Authors:  S F Davis; P M Strebel; W L Atkinson; L E Markowitz; R W Sutter; K S Scanlon; S Friedman; S C Hadler
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

9.  Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.

Authors:  C Pelissero; C Marena; F Aguzzi; M Bevilacqua; F Rebasti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

10.  Use of Capture-Recapture Analysis to Assess Reporting Completeness of Births to Hepatitis B-Positive Women in New York City, 2013-2014.

Authors:  Katelynn Devinney; Julie Lazaroff; Jennifer B Rosen; Christopher M Zimmerman; Jane R Zucker
Journal:  Public Health Rep       Date:  2020-04-08       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.